Company intelligence / Profile preview

DermaZinc

Cincinnati, Ohio, United States

Ownership: Private
Development stage: Other

Overview

DermaZinc is a pharmaceutical company specializing in over-the-counter (OTC) dermatological treatments for chronic skin conditions. The company's product line is centered around high-potency zinc pyrithione, formulated to manage symptoms of psoriasis, seborrheic dermatitis, and dandruff. DermaZinc offers various delivery formats, including soaps, creams, sprays, and shampoos, aimed at providing relief from itching, scaling, and redness. Their products are widely available through major retailers, pharmacies, and online channels. The company is recognized for providing professional-grade OTC solutions that bridge the gap between standard consumer products and prescription therapies.

Therapeutic areas: Dermatology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on DermaZinc.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DermaZinc.

Explore the full profile